XML 40 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Operating activities:    
Net income $ 273,538 $ 403,505
Less: Discontinued operations, net of tax (22,346) 137,629
Net income from continuing operations 295,884 265,876
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation of property and equipment, including internal-use software and website development 116,854 97,627
Amortization of stock-based compensation 48,910 39,334
Amortization of intangible assets 21,527 17,312
Deferred income taxes 16,219 8,746
Foreign exchange (gain) loss on cash, cash equivalents and short-term investments, net (18,348) 18,494
Realized loss on foreign currency forwards 8,511 8,117
Other 17,495 9,823
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable (192,105) (82,523)
Prepaid expenses and other current assets 1,253 (31,595)
Accounts payable, merchant 290,809 193,010
Accounts payable, other, accrued expenses and other current liabilities 204,345 78,122
Deferred merchant bookings 634,764 396,480
Deferred revenue 7,790 (125)
Net cash provided by operating activities from continuing operations 1,453,908 1,018,698
Investing activities:    
Capital expenditures, including internal-use software and website development (176,980) (157,867)
Purchases of investments (1,530,749) (1,179,555)
Sales and maturities of investments 1,244,065 1,046,395
Acquisitions, net of cash acquired (198,398) (8,076)
Net settlement of foreign currency forwards (8,511) (8,117)
Other, net (2,203) 1,039
Net cash used in investing activities from continuing operations (672,776) (306,181)
Financing activities:    
Treasury stock activity (366,037) (208,693)
Payment of dividends to stockholders (42,470) (57,732)
Proceeds from exercise of equity awards 232,658 23,127
Sales (purchases) of additional interests in controlled subsidiaries, net (2,015) 70,626
Excess tax benefit on equity awards 28,433 5,241
Changes in restricted cash and cash equivalents (2,752) (4,011)
Other, net (1,744) 2,182
Net cash provided by (used in) financing activities from continuing operations (153,927) (169,260)
Net cash provided by continuing operations 627,205 543,257
Net cash provided by (used in) discontinued operations (7,607) 114,412
Effect of exchange rate changes on cash and cash equivalents 5,996 (13,279)
Net increase in cash and cash equivalents 625,594 644,390
Cash and cash equivalents at beginning of period 689,134 621,199
Cash and cash equivalents at end of period 1,314,728 1,265,589
Supplemental cash flow information    
Cash paid for interest from continuing operations 85,255 86,907
Income tax payments (refunds), net from continuing operations $ (584) $ 16,237